logo
Plus   Neg
Share
Email

Kohl's Affirms FY19 Adj. EPS Guidance - Quick Facts

While reporting financial results for the second quarter on Tuesday, retailer Kohl's Corp. (KSS) affirmed its adjusted earnings guidance for the full-year 2019. For the second quarter, the company reported that comparable sales decreased 2.9 percent.

For fiscal 2019, the company said it continues to expect adjusted earnings in the range of $5.15 to $5.45 per share.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.23 per share for the year. Analysts' estimates typically exclude special items.

Last week, Kohl's Board of Directors declared a quarterly cash dividend on the Company's common stock of $0.67 per share, payable on September 25, 2019 to shareholders of record at the close of business on September 11, 2019.

"We are confident that our upcoming brand launches, program expansions, and increased traffic from the Amazon returns program will incrementally contribute to our performance during the balance of the year and beyond," said Michelle Gass, Kohl's chief executive officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>